Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Beta blockers and anesthesia].

J J Lehot1, P Foëx, P G Durand

  • 1Département d'Anesthésie et de Réanimation, Hôpital Cardiovasculaire et Pneumologique L. Pradel, Lyon.

Annales Francaises D'Anesthesie Et De Reanimation
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Innovations in management of cardiac disease: drugs, treatment strategies and technology.

British journal of anaesthesia·2017
Same author

Cohort study of preoperative blood pressure and risk of 30-day mortality after elective non-cardiac surgery.

British journal of anaesthesia·2017
Same author

Cohort study of preoperative blood pressure and risk of 30-day mortality after elective non-cardiac surgery.

British journal of anaesthesia·2017
Same author

Preoperative fast heart rate: a harbinger of perioperative adverse cardiac events.

British journal of anaesthesia·2016
Same author

Beta-blockade and other perioperative pharmacological protectors: what is now available and efficacious?

British journal of anaesthesia·2015
Same author

Reply from the authors.

British journal of anaesthesia·2014
Same journal

Annales francaises d'anesthesie et de reanimation·2020
Same journal

[Multimodal approach to enhance filter lifespan: are all actions equal?].

Annales francaises d'anesthesie et de reanimation·2014
Same journal

[Disparity of French Emergency medical services equipment: disparity of funding allocation or of management quality?].

Annales francaises d'anesthesie et de reanimation·2014
Same journal

[Eligibility to a Maastricht III - type organ donation according to the protocol proposed by the French organ procurement organization (Agence de la biomedicine) among patients in a medico surgical intensive care unit].

Annales francaises d'anesthesie et de reanimation·2014
Same journal

[Enhanced recovery after elective colorectal surgery: reply].

Annales francaises d'anesthesie et de reanimation·2014
Same journal

[Aorto-right atrial fistula as complication of aortic dissection].

Annales francaises d'anesthesie et de reanimation·2014
See all related articles

Beta-adrenoceptor antagonists (BB) manage heart conditions by blocking adrenaline. Careful perioperative use of BB improves patient stability and avoids adverse effects during anesthesia.

Area of Science:

  • Pharmacology
  • Cardiology
  • Anesthesiology

Context:

  • Beta-adrenoceptor antagonists (BB) competitively inhibit endogenous catecholamines.
  • BBs target beta-1 receptors for cardiac effects and beta-2 for smooth muscle effects.
  • BBs are crucial for treating ischemic heart disease, hypertension, and arrhythmias.

Purpose:

  • To review the mechanisms, applications, and perioperative considerations of beta-adrenoceptor antagonists.
  • To highlight the risks and benefits of BB use in patients undergoing anesthesia.
  • To discuss specific clinical scenarios and the role of novel BBs like esmolol.

Summary:

  • Beta-1 blockade depresses cardiac contractility, heart rate, and AV conduction.
  • Beta-2 blockade causes smooth muscle constriction in vasculature, bronchi, and uterus.

Related Experiment Videos

  • BBs with selective beta-1 activity and intrinsic sympathomimetic action do not elevate systemic vascular resistance.
  • Key perioperative hazards include bradycardia, hypotension, and bronchospasm.
  • Premedication with BBs enhances perioperative hemodynamic stability and prevents rebound effects.
  • Oxprenolol has shown efficacy in reversing myocardial dysfunction under anesthesia.
  • Intravenous BBs require cautious use for post-anesthetic hypertension with tachycardia.
  • BBs potentiate other agents in controlled hypotension and manage tachycardia in pheochromocytoma surgery.
  • Pre-induction BB administration in coronary artery bypass surgery reduces cardiac enzyme levels.
  • Esmolol offers rapid control of perioperative tachycardia and hypertension without prolonged cardiac depression.

    • Impact:

    • Optimizing beta-blocker management in anesthesia improves patient outcomes.
    • Understanding BB pharmacology is vital for safe perioperative care.
    • Novel BBs like esmolol provide enhanced control in critical surgical settings.